PNC Financial Services Group
CTSO icon

PNC Financial Services Group’s Cytosorbents Corp CTSO Stock Holding History

PNC Financial Services Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12 Hold
31
– – ﹤0.01% 5202
2026
Q1 		$18 Hold
31
– – ﹤0.01% 5147
2025
Q4 		$20 Hold
31
– – ﹤0.01% 5133
2025
Q3 		$29 Hold
31
– – ﹤0.01% 5052
2025
Q2 		$40 Hold
31
– – ﹤0.01% 4870
2025
Q1 		$31 Hold
31
– – ﹤0.01% 4858
2024
Q4 		$28 Hold
31
– – ﹤0.01% 4748
2024
Q3 		$47 Hold
31
– – ﹤0.01% 4748
2024
Q2 		$22 Hold
31
– – ﹤0.01% 4739
2024
Q1 		$29 Sell
31
-5
-14% -$5 ﹤0.01% 4671
2023
Q4 		$40 Buy
+36
New +$53 ﹤0.01% 4579
2018
Q4 		– Sell
-30,500
Closed -$393K – 4060
2018
Q3 		$393K Buy
30,500
+10,000
+49% +$125K ﹤0.01% 1806
2018
Q2 		$234K Buy
20,500
+1,000
+5% +$9.47K ﹤0.01% 2105
2018
Q1 		$137K Buy
19,500
+4,500
+30% +$34K ﹤0.01% 2386
2017
Q4 		$98K Sell
15,000
-5,000
-25% -$31.8K ﹤0.01% 2579
2017
Q3 		$124K Sell
20,000
-18,000
-47% -$91.7K ﹤0.01% 2406
2017
Q2 		$163K Buy
38,000
+22,500
+145% +$98.6K ﹤0.01% 2253
2017
Q1 		$70K Buy
15,500
+5,500
+55% +$30.7K ﹤0.01% 2720
2016
Q4 		$55K Hold
10,000
– – ﹤0.01% 2786
2016
Q3 		$64K Sell
10,000
-200
-2% -$1.04K ﹤0.01% 2698
2016
Q2 		$46K Buy
10,200
+2,500
+32% +$10.9K ﹤0.01% 2871
2016
Q1 		$30K Buy
7,700
+3,000
+64% +$13K ﹤0.01% 3063
2015
Q4 		$26K Buy
4,700
+4,500
+2,250% +$30.6K ﹤0.01% 3163
2015
Q3 		$1K Hold
200
– – ﹤0.01% 4448
2015
Q2 		$1K Hold
200
– – ﹤0.01% 4542
2015
Q1 		$3K Buy
200
+100
+100% +$1.03K ﹤0.01% 4164
2014
Q4 		$1K Buy
+100
New +$979 ﹤0.01% 3979

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

PNC Financial Services Group's CTSO Position: Q2 2026 in Review

PNC Financial Services Group held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 31 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #5202.

PNC Financial Services Group first reported a position in CTSO in Q4 2014 and has held it in 27 quarters since. The position peaked at $393K in Q3 2018. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • PNC Financial Services Group held 31 shares of Cytosorbents Corp worth $12 as of Q2 2026.
  • PNC Financial Services Group left its Cytosorbents Corp share count unchanged in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5202 holding.
  • PNC Financial Services Group first reported a position in Cytosorbents Corp in Q4 2014 and has held it in 27 quarters since.
  • PNC Financial Services Group's Cytosorbents Corp position peaked at $393K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.